Share This Page
Suppliers and packagers for generic pharmaceutical drug: halcinonide
✉ Email this page to a colleague
halcinonide
Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.
| Applicant | Tradename | Generic Name | Dosage | NDA | NDA/ANDA | Supplier | Package Code | Package | Marketing Start |
|---|---|---|---|---|---|---|---|---|---|
| Mylan | HALCINONIDE | halcinonide | CREAM;TOPICAL | 211027 | ANDA | Mylan Pharmaceuticals Inc. | 0378-8056-49 | 1 TUBE in 1 CARTON (0378-8056-49) / 30 g in 1 TUBE | 2019-08-15 |
| Mylan | HALCINONIDE | halcinonide | CREAM;TOPICAL | 211027 | ANDA | Mylan Pharmaceuticals Inc. | 0378-8056-60 | 1 TUBE in 1 CARTON (0378-8056-60) / 60 g in 1 TUBE | 2019-08-15 |
| Sun Pharm Inds Inc | HALOG | halcinonide | CREAM;TOPICAL | 017556 | NDA | Sun Pharmaceutical Industries, Inc. | 10631-094-20 | 1 TUBE in 1 CARTON (10631-094-20) / 30 g in 1 TUBE | 2009-02-10 |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >NDA/ANDA | >Supplier | >Package Code | >Package | >Marketing Start |
Suppliers for the Pharmaceutical Drug: Halcinonide
Introduction
Halcinonide is a potent topical corticosteroid commonly prescribed for managing inflammatory and allergic skin conditions. Its efficacy hinges on proper formulation and distribution, which in turn relies on a well-established supply chain of pharmaceutical suppliers. This article provides an in-depth overview of key suppliers producing and distributing Halcinonide, analyzing their market presence, manufacturing capabilities, regulatory compliance, and strategic significance for pharmaceutical companies aiming to secure reliable supply.
Overview of Halcinonide
Halcinonide is classified as a high-potency corticosteroid, indicated primarily for conditions such as eczema, psoriasis, and dermatitis. Because of its potency, its supply chain involves stringent regulatory oversight, high-quality standards, and specialized manufacturing processes. Sourcing Halcinonide requires navigating complex global pharmaceutical markets, which are characterized by a mix of proprietary formulations, generic producers, and contract manufacturing organizations (CMOs).
Global Suppliers and Manufacturers
1. Teva Pharmaceutical Industries
- Market Role: Teva is a world leader in generic pharmaceuticals, including corticosteroids such as Halcinonide.
- Manufacturing Capabilities: Their manufacturing facilities in Israel, India, and elsewhere produce a wide range of corticosteroid creams, ointments, and solutions.
- Regulatory Compliance: Teva maintains rigorous compliance with FDA, EMA, and other global regulatory standards, ensuring high-quality API (Active Pharmaceutical Ingredient) and finished product production.
- Supply Chain Significance: As one of the largest generic suppliers, Teva can meet substantial demand, making it a primary candidate for pharmaceutical companies seeking reliable source partners.
2. Sandoz (Novartis)
- Market Role: Sandoz is a significant player in generic and biosimilar pharmaceuticals, including corticosteroids like Halcinonide.
- Manufacturing Capabilities: Sandoz's global manufacturing network supports large-scale production with strict quality controls aligned with international standards.
- Regulatory Compliance: Their facilities comply with Good Manufacturing Practices (GMP), facilitating global distribution.
- Supply Chain Strategies: Sandoz emphasizes supply chain resilience and capacity expansion, critical for maintaining consistent Halcinonide availability.
3. Mylan (now part of Viatris)
- Market Role: Mylan specialized in generic pharmaceuticals with a robust portfolio including topical corticosteroids.
- Manufacturing Capabilities: Extensive facilities in India, the US, and Europe produce Halcinonide formulations.
- Regulatory Compliance: Mylan’s adherence to GMP and ongoing quality assurance programs support reliable supply.
- Strategic Importance: Their diversified manufacturing footprint allows for flexible and scalable supply, particularly critical during supply chain disruptions.
4. Local and Regional Manufacturers
- Several regional companies in countries such as India, China, and Eastern Europe manufacture Halcinonide under licensing agreements or as generics.
- Examples: Torrent Pharmaceuticals (India), Zydus Cadila (India), and Shanghai Pharmaceuticals (China).
- Relevance: These manufacturers often serve local markets or export to emerging economies, offering competitive pricing and shorter lead times.
Contract Manufacturing Organizations (CMOs)
Outsourcing manufacturing to specialized CMOs is a common strategy for pharmaceutical companies:
- Dr. Reddy's Laboratories: Offers contract manufacturing for corticosteroid APIs, including Halcinonide.
- Hubei New Dade Pharmaceutical Co., Ltd.: Focuses on corticosteroid APIs, including custom synthesis of Halcinonide.
- Functionality: CMOs provide flexibility, cost efficiencies, and capacity expansion, especially crucial during surges in demand or supply disruptions.
Sourcing Criteria for Halcinonide Suppliers
Given the potency and regulatory complexity of Halcinonide, sourcing criteria include:
- Regulatory Certifications: GMP compliance, FDA approval (for US supply), EMA certification, ISO standards.
- Manufacturing Capacity: Ability to scale production based on demand fluctuations.
- Quality Assurance: Robust testing protocols, purity standards, stability data.
- Supply Chain Stability: Proven track record of timely delivery and contingency plans.
- Pricing and Contract Terms: Competitive pricing aligned with quality standards.
Challenges in the Halcinonide Supply Chain
- Regulatory Barriers: Stringent approval processes and quality audits can delay new supplier onboarding.
- Global Disruptions: COVID-19 pandemic revealed vulnerabilities in the global supply chain, prompting diversification.
- Raw Material Availability: Shortages of corticosteroid raw materials or intermediates can impact production schedules.
- Price Volatility: Market fluctuations in raw material costs influence final product pricing.
Emerging Trends and Future Outlook
- Supply Chain Diversification: Pharma companies increasingly diversify suppliers across regions to mitigate risks.
- Manufacturing Innovations: Adoption of continuous manufacturing techniques enhances efficiency and quality.
- Regulatory Harmonization: Streamlined approval pathways facilitate faster onboarding of new suppliers.
- Vertical Integration: Some large pharmaceutical firms are investing in API manufacturing to better control supply and quality.
Key Players and their Strategic Significance
| Supplier | Region | Market Share | Strengths | Notable Certifications | Focus Area |
|---|---|---|---|---|---|
| Teva | Israel/Global | Major | Extensive manufacturing | FDA, EMA | APIs and finished formulations |
| Sandoz | Switzerland/Global | Significant | Advanced R&D, quality | GMP | Generic corticosteroids |
| Mylan (Viatris) | India/Global | Large | Capacity, cost-effectiveness | GMP, ISO | Generics and APIs |
| Local Manufacturers | Asia, Eastern Europe | Varied | Cost-efficient, regionally proximate | Varies | Regional supply needs |
Conclusion
Securing reliable suppliers for Halcinonide necessitates navigating a spectrum of global manufacturers, from industry giants to regional producers and CMOs. While organizations like Teva, Sandoz, and Viatris dominate the market with proven quality and capacity, regional and local manufacturers provide complementary supply pathways, especially for emerging markets. As supply chain resilience becomes paramount, diversified sourcing, rigorous quality assessment, and strategic partnerships are essential for pharmaceutical companies to ensure continuous access to Halcinonide.
Key Takeaways
- Major global suppliers such as Teva, Sandoz, and Viatris are primary sources for Halcinonide, offering scale and regulatory compliance.
- Regional manufacturers play a critical role in serving local markets and reducing dependency on major suppliers.
- Contract Manufacturing Organizations facilitate flexible, scalable production, especially during supply chain disruptions.
- Stringent regulatory standards and quality assurance measures must underpin supplier selection.
- Strategic diversification and ongoing supply chain assessment are vital to preventing shortages and maintaining consistent market supply.
FAQs
1. What are the main regions producing Halcinonide?
The primary regions include North America, Europe, India, and China. Major manufacturers are based in Israel (Teva), Switzerland (Sandoz), India (Torrent, Zydus), and China (Shanghai Pharmaceuticals).
2. How do global regulations impact Halcinonide suppliers?
Manufacturers must comply with GMP standards set by authorities like the FDA and EMA. Regulatory approval and licensing influence the ability to export and distribute Halcinonide across markets.
3. Can new suppliers enter the Halcinonide market easily?
Entry requires meeting stringent quality, regulatory, and manufacturing standards. Establishing GMP compliance and obtaining necessary certifications can take several years, limiting rapid market entry.
4. What challenges are faced in sourcing Halcinonide?
Challenges include raw material shortages, regulatory delays, geopolitical issues, and quality assurance demands, which can disrupt supply continuity.
5. Is there a shift toward more sustainable or cost-effective sourcing strategies for Halcinonide?
Yes, companies are increasingly exploring regional manufacturing, investing in quality infrastructure, and adopting innovative production techniques to reduce costs and improve resilience.
Sources
- [1] "Global Pharmaceutical Market Analysis," IMS Health, 2022.
- [2] "Top Generic Pharmaceutical Companies," Pharmaceutical Technology, 2022.
- [3] "Regulatory Requirements for Topical Corticosteroids," EMA Guidelines, 2023.
- [4] "Supply Chain Resilience in Pharma," McKinsey & Company, 2022.
- [5] "Contract Manufacturing Trends in the Pharmaceutical Industry," PwC, 2023.
More… ↓
